1
Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer
Condition(s):HR+/HER2- Breast CancerLast Updated:February 21, 2023Recruiting
HR HER2- Breast Cancer: 484 Clinical Trials, Page 1 of 49
Hide Studies Not Open or Pending
2
Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer
Condition(s):Breast CancerLast Updated:August 23, 2022Not yet recruiting
3
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
Condition(s):HR Positive HER2 Negative Advanced Breast CancerLast Updated:June 6, 2023Recruiting
4
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
Condition(s):Breast CancerLast Updated:August 4, 2023Recruiting
5
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer
Condition(s):Breast CancerLast Updated:August 14, 2023Active, not recruiting
6
Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer
Condition(s):Advanced Breast Cancer; Hormone Receptor Positive Breast Carcinoma; HER2-negative Breast CancerLast Updated:January 25, 2023Recruiting
7
Study Evaluating Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients w/ Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Condition(s):Breast CancerLast Updated:June 7, 2023Active, not recruiting
8
Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index
Condition(s):Breast CancerLast Updated:February 15, 2023Recruiting
9
Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy
Condition(s):Hormone Receptor-positive Advanced Breast CancerLast Updated:April 10, 2023Not yet recruiting
10
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
Condition(s):Breast CancerLast Updated:July 27, 2023Recruiting